Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Ruggiero

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Current Pharmaceutical Design|December 28, 2010
Helicobacter pylori and inflammationPaolo Ruggiero
Current Opinion in Infectious Diseases|May 5, 2012
Helicobacter pylori infection: what's newPaolo Ruggiero
World Journal of Gastrointestinal Pathophysiology|November 18, 2014
Use of probiotics in the fight against Helicobacter pyloriPaolo Ruggiero
Frontiers in Immunology|October 18, 2013
Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer VaccineMarkus Stein, Paolo Ruggiero, Rino Rappuoli, et al.
Microbes and Infection|June 20, 2003
The quest for a vaccine against Helicobacter pylori: how to move from mouse to man?Paolo Ruggiero, Samuele Peppoloni, Rino Rappuoli, et al.
BMC Biotechnology|November 2, 2004
Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteriaStefano Porzio, Paola Bossù, Paolo Ruggiero, et al.
Archives of Biochemistry and Biophysics|November 4, 2017
CagL from Helicobacter pylori has ADP-ribosylation activity and exerts partial protective efficacy in miceEleonora Talluri, Laura Pancotto, Paolo Ruggiero, et al.
Journal of Medical Microbiology|December 10, 2003
Effect of heparin binding on Helicobacter pylori resistance to serumJ Daniel Dubreuil, Paolo Ruggiero, Rino Rappuoli, et al.
The Journal of Infectious Diseases|July 26, 2012
Exogenous sialic acid transport contributes to group B streptococcus infection of mucosal surfacesAlfredo Pezzicoli, Paolo Ruggiero, Fulvia Amerighi, et al.
Expert Opinion on Investigational Drugs|August 2, 2002
New strategies for the prevention and treatment of Helicobacter pylori infectionPaolo Ruggiero, Samuele Peppoloni, Duccio Berti, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Design|December 28, 2010
Helicobacter pylori and inflammationPaolo Ruggiero
Current Opinion in Infectious Diseases|May 5, 2012
Helicobacter pylori infection: what's newPaolo Ruggiero
World Journal of Gastrointestinal Pathophysiology|November 18, 2014
Use of probiotics in the fight against Helicobacter pyloriPaolo Ruggiero
Frontiers in Immunology|October 18, 2013
Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer VaccineMarkus Stein, Paolo Ruggiero, Rino Rappuoli, et al.
Microbes and Infection|June 20, 2003
The quest for a vaccine against Helicobacter pylori: how to move from mouse to man?Paolo Ruggiero, Samuele Peppoloni, Rino Rappuoli, et al.
BMC Biotechnology|November 2, 2004
Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteriaStefano Porzio, Paola Bossù, Paolo Ruggiero, et al.
Archives of Biochemistry and Biophysics|November 4, 2017
CagL from Helicobacter pylori has ADP-ribosylation activity and exerts partial protective efficacy in miceEleonora Talluri, Laura Pancotto, Paolo Ruggiero, et al.
Journal of Medical Microbiology|December 10, 2003
Effect of heparin binding on Helicobacter pylori resistance to serumJ Daniel Dubreuil, Paolo Ruggiero, Rino Rappuoli, et al.
The Journal of Infectious Diseases|July 26, 2012
Exogenous sialic acid transport contributes to group B streptococcus infection of mucosal surfacesAlfredo Pezzicoli, Paolo Ruggiero, Fulvia Amerighi, et al.
Expert Opinion on Investigational Drugs|August 2, 2002
New strategies for the prevention and treatment of Helicobacter pylori infectionPaolo Ruggiero, Samuele Peppoloni, Duccio Berti, et al.
Pageof 4